Your Most Valuable QA and Dosimetry Tools

NEWS

News > Sun Nuclear Hosts 170+ Medical Physicists at 2018 QA & Dosimetry Symposium

Sun Nuclear Hosts 170+ Medical Physicists at 2018 QA & Dosimetry Symposium

Conference focused on the latest practices and issues related to QA and Dosimetry in Radiation Oncology

Melbourne, Florida –On March 9-10, 2018, Sun Nuclear Corporation welcomed more than 170 Medical Physicists and Dosimetrists from around the world to its 11th QA & Dosimetry Symposium (QADS). Held in Orlando, Florida, this continuing education event included 24 talks on best practices for QA and dosimetry in radiation therapy. 

Thought leaders from the field, including Lawrence Marks, M.D., Bruce Thomadsen, Ph.D., Gary Ezzell, Ph.D., and Ronald Chen, M.D., M.P.H., among others, addressed initiatives around patient safety best practices. Topics ranged from safety initiatives in progress by the American Association of Physicists in Medicine (AAPM), to better use of big data, to best practices for quality assurance in new and emerging modalities.

“We were thrilled to have speakers with a wide range of experience,” noted Jie Shi, Ph.D., QADS Program Director. “Attendees were able to take away practical clinical tools from the topics presented.”

In addition to the patient safety themes, presenters addressed practical use of advanced QA tools to support their radiotherapy techniques:

  • Robert Staton, Ph.D., of Orlando Health UF Health Cancer Center, spoke about implementing SunCHECK™, a unified QA software platform, at his clinic
  • Tucker Netherton, D.M.P., described his experience commissioning a Varian Halcyon™ treatment system 
  • Brett Miller, M.S., of The University of Tennessee Medical Center, detailed his experience replacing film with an electronic array (SRS MapCHECK™) for stereotactic patient-specific QA
  • Salvadore Gerace, Ph.D., of ProKnow Systems, revealed the winners of the 2018 World Championship of Treatment Planning

The next QADS is planned for 2020. Stay tuned for details on an exciting new vision for the future.